Sponsor

Tasly Pharmaceutical Group Co., Ltd

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Tasly Pharmaceutical Group Co., Ltd appears in 11 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials11
Recruiting shown3
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

11 shown
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUreNCT07687186 · lead sponsor · 2026-06-22
RECRUITING
TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary EfficacyNCT07514065 · lead sponsor · 2026-02-20
RECRUITING
A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart FailureNCT07265349 · lead sponsor · 2025-12-26
RECRUITING
A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe DepressionNCT07485595 · lead sponsor · 2026-04-30
NOT_YET_RECRUITING
Efficacy and Safety of Jia Shen Tablets in Chronic Heart FailureNCT06669169 · lead sponsor · 2025-01-31
NOT_YET_RECRUITING
A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease PsychosisNCT06068465 · lead sponsor · 2024-09-27
COMPLETED
Pharmacokinetic and Pharmacodynamic of Jia Shen Tablets in Chronic Heart FailureNCT06348498 · lead sponsor · 2024-04-09
UNKNOWN
A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe DepressionNCT06259526 · lead sponsor · 2023-12-26
COMPLETED
Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)NCT06006689 · lead sponsor · 2023-09-04
UNKNOWN
Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection FractionNCT04944706 · lead sponsor · 2021-07-27
COMPLETED
Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart FailureNCT04983043 · lead sponsor · 2021-06-10
COMPLETED

Drugs studied in this sponsor's trials

2 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Tasly Pharmaceutical Group Co., Ltd as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
pimavanserin tartrate1
placebo1

Sponsor roles

lead sponsor11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.